Decreased percentage of NKG2D+NK cells in patients with incident onset of Type 1 Diabetes
- 24 January 2017
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 44 (2) , 180-190
Abstract
Summary: Type 1 diabetes mellitus (T1DM) is characterized by absolute insulin deficiency owing to autoimmune destruction of the pancreatic β cells. A significant decrease in natural killer (NK) cells in peripheral blood has been observed in patients with untreated T1DM. In the present study, we aimed to explore the role of NK cells and their subsets in young T1DM patients. A total of 30 children and adolescents with untreated T1DM and 27 healthy controls (HC) were recruited in this study. Flow cytometry analysis indicated that the percentage of peripheral blood CD3‐CD56+ NK cells and NK cells subsets (CD56bright, CD56dim and CD56neg), were significantly decreased in the T1DM patients compared to healthy controls. In addition, the percentage of inducible CD107a+ and IFN‐γ‐secreting NK cells was significantly decreased compared to HC. Interestingly, the percentage of NKG2D+ NK cells negatively correlated with the level of serum TCHOL and TG in T1DM patients. Our data indicate that decreased number and impaired function of NK cells may have a role in the pathogenesis of T1DM.Keywords
Funding Information
- Jilin University (A04)
This publication has 38 references indexed in Scilit:
- Control of Human Viral Infections by Natural Killer CellsAnnual Review of Immunology, 2013
- An indirect role for NK cells in a CD4+ T‐cell‐dependent mouse model of type I diabetesImmunology & Cell Biology, 2011
- Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic MiceThe Journal of Immunology, 2010
- Functions of natural killer cellsNature Immunology, 2008
- Natural killer cells are required for accelerated type 1 diabetes driven by interferon-βClinical and Experimental Immunology, 2008
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patientsProceedings of the National Academy of Sciences, 2007
- Altered Natural Killer Cells in Type 1 Diabetic PatientsDiabetes, 2007
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005
- Insulin therapy corrects NK cells abnormality in type I diabetes mellitus patientsBiomedicine & Pharmacotherapy, 1996
- Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitusImmunology Letters, 1984